Arrowhead Pharmaceuticals
ARWR
#2176
Rank
S$11.00 B
Marketcap
S$79.62
Share price
-4.98%
Change (1 day)
166.74%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2025 (TTM): -S$82.89 Million

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are S$0.57 Billion. In 2024 the company made an earning of -S$0.78 Billion a decrease over its 2023 earnings that were of -S$0.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$82.89 Million-89.34%
2024 -S$0.78 Billion112.45%
2023 -S$0.37 Billion87.79%
2022 -S$0.2 Billion-20.1%
2021 -S$0.25 Billion67.59%
2020 -S$0.15 Billion-347.53%
2019 S$58.82 M-245.59%
2018 -S$40.41 Million-13.17%
2017 -S$46.54 Million-52.28%
2016 -S$97.52 Million-16.57%
2015 -S$0.12 Billion30.32%
2014 -S$89.69 Million171.62%
2013 -S$33.03 Million16.56%
2012 -S$28.33 Million107.53%
2011 -S$13.66 Million
2008 -S$48.09 Million-8.07%
2007 -S$52.31 Million70.37%
2006 -S$30.7 Million122.51%
2005 -S$13.8 Million147.41%
2004 -S$5.58 Million2002.28%
2003 -S$0.27 Million-85.61%
2002 -S$1.85 Million1371.97%
2001 -S$0.13 Million-13.45%
2000 -S$0.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Alnylam Pharmaceuticals
ALNY
S$0.16 B-273.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-S$0.16 Billion 56.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$86.55 M-188.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-S$0.15 Billion 43.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$41.98 B-43,253.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-S$4.08 Billion 4,089.31%๐Ÿ‡บ๐Ÿ‡ธ USA